EMGENISYS
EMGenisys offers an embryo health assessment platform that determines embryo viability and sex in a single assessment in the lab. Its technology utilizes video motion magnification to determine if cells are actively dividing or decaying, ensuring the embryos are alive and healthy at the time of transfer. It aims to improve animal production to further sustainability and promote animal welfare through advancements in reproductive technologies.
EMGENISYS
Social Links:
Industry:
Agriculture AgTech Biotechnology Health Care Life Science
Address:
Houston, Texas, United States
Country:
United States
Status:
Active
Contact:
+1 281-728-0491
Total Funding:
9 K USD
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Texas A&M New Ventures Competition
Texas A&M New Ventures Competition investment in Grant - EMGenisys
Texas A&M New Ventures Competition
Texas A&M New Ventures Competition investment in Grant - EMGenisys